12,558 results match your criteria: "Triazenes"

I
In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment.
Yang Liu, Lin Cui, Xiao Wang, Weiling Miao, Yongxu Ju

Adv Sci (Weinh)· June 2023

Videos about Article: user

1 1 3

View All Article and Social Media Activity
P
Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
Thomas N Seyfried, Laura Shelton, Gabriel Arismendi-Morillo, Miriam Kalamian, Ahmed Elsakka

Neurochem Res· October 2019

Videos about Article: user user user

3 3 247 1 2 2

View All Article and Social Media Activity
T
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy.
Giulia Lori, Paolo Paoli, Anna Caselli, Paolo Cirri, Riccardo Marzocchini

Cancer Med· May 2018

Videos about Article: user

1 1

View All Article and Social Media Activity
[
[Case of Successful Desensitization with Temozolomide in a Patient with Severe Skin Reaction].
Pamela Salman, Magdalena Abbott-Croxatto, Camila Urrea, Bárbara Cabrera

Rev Med Chil· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Retrospective Evaluation of the Clinical Value of Interim PET-CT in Hodgkin Lymphoma Treated with ABVD (2017-2023)].
Juan Manuel Domínguez, Pablo Gatto, Joaquín Lima, María Eugenia Rodríguez, Luis Eduardo Topolansky

Rev Med Chil· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIM67 Suppresses Glioblastoma Glycolysis and Increases Temozolomide Sensitivity by Promoting ARSD Ubiquitinated Degradation to Inactivate the β-Catenin Pathway.
Xuzhao Li, Fangzhou Guo, Lixin Xu, Haozhe Piao

FASEB J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RBM7 suppresses mitochondrial dysfunction and ferroptosis by destabilizing FBXL16 mRNA to enhance Temozolomide resistance in glioblastoma.
Nan Liu, YeTing Cui, Juan Li, SuMei Li, YanYang Tu

Mol Genet Genomics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruiting T-cells toward the brain for enhanced glioblastoma chemo-immunotherapy efficacy by co-delivery of cytokines and temozolomide via ultrasound-gated redox-responsive extracellular vesicles.
Lei Dong, Qing Xu, Hanjiao Liu, Ran Li, Zhengcheng Yun

J Nanobiotechnology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linear triazenes: Versatile scaffolds for chemical biology and drug design.
Ahammed Ameen Thottasseri, Anju Agnes Tom, Deepthi Ramesh, Ramkishore Matsa, Tharanikkarasu Kannan

Drug Discov Today· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Schisandrin B and Temozolomide Treatment Induces Mitochondrial Apoptosis in Glioma Cells.
Zebo Tang, Chaoran Guo, Na Wen, Hong Jin, Yuan Dong

Front Biosci (Landmark Ed)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic antiproliferative and pro-apoptotic activity of dacarbazine combined with 2-aminoethyl dihydrogen phosphate in melanoma cells.
Thalles Anthony Duarte de Oliveira, Gustavo Henrique Doná Rodrigues Almeida, Ranya Sthephanie Nascimento Ribeiro, Rosa Andrea Nogueira Laiso, Monique Gonçalves Alves

Biomed Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
β-Lapachone sensitizes glioblastoma to Temozolomide by inhibiting NF-κB signaling.
Chunhua Quan, Ying Liu, Yuan Gao, Houkun Zhou, Haiyan Quan

Funct Integr Genomics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoradiotherapy with temozolomide vs. radiotherapy alone in patients with IDH wild-type and TERT promoter mutation histological grade 2/3 gliomas: An extension retrospective analysis of a randomized controlled trial.
Jing Zhang, Peng Wang, Yin Ren, Li Chen, Jin Feng

Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal qMSP cutoff value for MGMT promoter methylation in glioblastoma and its validation for clinical significance.
Zeynep Huseyinoglu, Ece Uysal, Mehmet Arda Inan, Turna Demirci, Guzin Gokay

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMEM165 promotes glioblastoma progression through epithelial-mesenchymal transition-mediated invasion and temozolomide chemoresistance.
Honglei Cheng, Yueju Ding, Xinan Shen, Qing Wang, Zhicheng Zhang

Int J Biol Macromol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial.
Graeme F Woodworth, Pavlos Anastasiadis, Ahmad Ozair, Jeremi Chabros, Chetan Bettegowda

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial cells sense temozolomide resistance to facilitate monocyte-derived macrophage infiltration in glioblastoma.
Wei Gao, Jianliang Huang, Kun Deng, Xiang Lin, Xinmiao Long

Drug Resist Updat· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma.
Emilie Le Rhun, Debaleena Sain, Sara C Erridge, David A Reardon, Giuseppe Minniti

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNaseH2 inhibition potentiates temozolomide response in patient derived glioblastoma cells.
Miroslava Kissova, Judit Martinez Segarra, Tobias Solli Iveland, Marthe Vestvik, Erlend Ravlo

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of valsartan in overcoming chemoresistance in human glioblastoma.
Jia-Rong Hu, Ying Kao, Yung-Lung Chang, Fu-Chi Yang, Chia-Kuang Tsai

Sci Prog· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib and temozolomide combination in relapsed metastatic Ewing sarcoma brings a new ray of hope.
Deepak Gupta, Pawan Agarwal, Ajay Singh Chaudhary, Anushka Gupta

Indian J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of temozolomide dosing on outcome in glioblastoma.
Anuradha Raghu, Sofia Killar, Adam L Cohen

J Neurooncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Validated UPLC-MS/MS Method for Monitoring Temozolomide and Perillyl Alcohol Metabolites in Biological Matrices: Insights From a Preclinical Pharmacokinetic Study.
Ariane Krause Padilha Lorenzett, Tatiane Patricia Babinski, Samila Horst Peczek, Ana Paula Tartari, Jeferson Ziebarth

Biomed Chromatogr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemoradiotherapy with procarbazine, lomustine, and vincristine (PCV) or temozolomide for 1p/19q Co-deleted anaplastic oligodendroglioma: a systematic review and network meta-analysis.
Monica D'Alma Costa Santos, Natasha Maranhão Vieira Rodrigues, Franceliny Gibram, Felipe Araujo Gouhie, Ana Carolina Pinheiro Campos

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resveratrol Sensitizes Temozolomide-Resistant Glioblastoma Cells Through Mitogen-Activated Protein Kinase Pathway Inhibition and P-Glycoprotein Modulation.
Maede Rezaie, Mohammad Nasehi, Dariush Shanehbandi, Amir Valizadeh, Bahman Yousefi

Drug Res (Stuttg)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide-induced senescent glioblastoma cells acquire sensitivity to TRAIL death receptor 5-mediated apoptosis.
Alina A Isakova, Diana V Mazur, Nadezhda V Antipova, Irina N Druzhkova, Аrtem М Mozherov

Med Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiforme.
Johannes Pärtel Truusalu, Kersti Oselin, Jana Lass, Kristen K Buck, William Sietsema

BMJ Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Assembling Nanoparticles Orchestrate Cuproptosis-Immunotherapy Synergy to Suppress Postoperative Glioma Recurrence.
Chao Zhang, Shiqiang Hou, Ben Hu, Ziying Wu, Xinwei Li

ACS Appl Mater Interfaces· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovery of glioblastoma cells derived from patients after a decade of cryopreservation for drug response studies.
Wannawat Khotchawan, Chanchao Lorthongpanich, Pakpoom Kheolamai, Sith Sathornsumetee, Surapol Issaragrisil

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistance.
Gatikrushna Singh, Shilpi Singh, Iteeshree Mohapatra, Stefan Kim, Mayur Sharma

Cell Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis